Evolent forecasts 30% revenue growth in 2026 driven by oncology and enhanced contracts
Source: SeekingAlpha
2026-02-25 12:28:38 ET
More on Evolent Health
- Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
- Evolent Health, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Evolent Health downgraded at KeyBanc on EBITDA recovery concerns
- Evolent Health Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Evolent Health
Read the full article on Seeking Alpha
For further details see:
Evolent forecasts 30% revenue growth in 2026 driven by oncology and enhanced contracts
Evolent Health Inc Class A
NASDAQ: EVH
EVH Trading
-1.4% G/L:
$3.17 Last:
642,739 Volume:
$3.39 Open:
EVH Latest News
February 24, 2026 04:10:00 pm
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
EVH Stock Data
$308,018,363
110,038,444
0.05%
74
N/A
Healthcare Providers & Services
Healthcare
US
Arlington
